ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹922 Cr | ₹819 Cr | ₹666 Cr | ₹560 Cr | ₹450 Cr |
What is the latest Revenue of ORCHID PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹922 Cr |
| Mar2024 | ₹819 Cr |
| Mar2023 | ₹666 Cr |
| Mar2022 | ₹560 Cr |
| Mar2021 | ₹450 Cr |
How is Revenue of ORCHID PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹922 Cr | 12.52 | |
| Mar2024 | ₹819 Cr | 23.05 | |
| Mar2023 | ₹666 Cr | 19.00 | |
| Mar2022 | ₹560 Cr | 24.33 | |
| Mar2021 | ₹450 Cr | - | |
Compare Revenue of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,892.4 Cr | 2% | 11.3% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 2% |
11.3% |
-20% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses